Biotech · Private company
Recognify Life Sciences
Track this companyFree. Adds Recognify Life Sciences to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- RL-007Phase 2 · Cognitive ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- RL-007 (Inidascamine)Phase 2 · Cognitive Impairment Associated With Schizophrenia (CIAS)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)PHASE2 · COMPLETED · started Dec 8, 2022ClinicalTrials.gov NCT05686239 · fetched Nov 12, 2026
- Safety, Biomarker Study of RL-007 in Subjects With SchizophreniaPHASE2 · COMPLETED · started Apr 26, 2021ClinicalTrials.gov NCT04822883 · fetched Nov 12, 2026